Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | CD69 | Q07108 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | PYGB | P11216 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | OGA | O60502 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14823585 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL12295742 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL15616403 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL12733141 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL12337162 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL13498558 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL16076955 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL9914010 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL20626631 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 | |
| SCHEMBL13541586 | 1.00 | ALDH1A1 (0.56) | ALDH1A1THRBMAPK1CD69SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100016547-A1 | Glycosilated Peptide and Medicine Comprising It as an Effective Ingredient | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2010-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016547-A1 | Glycosilated Peptide and Medicine Comprising It as an Effective Ingredient | GLP1R, VIP, IAPP | ALDH1A1 1989/4885THRB 2051/4885MAPK1 1433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.